HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 201 | 231 | 87.0% | |
| HF 4 | 2012 | 203 | 230 | 88.3% | |
| HF 4 | 2013 | 234 | 249 | 94.0% | |
| HF004 | 2014 | 127 | 142 | 89.4% | |
| HF004 | 2015 | 133 | 141 | 94.3% | |
| HF004 | 2016 | 130 | 143 | 90.9% | |
| HF004 | 2017 | 146 | 156 | 93.6% | |
| HF004 | 2018 | 156 | 167 | 93.4% | |
| HF004 | 2019 | 161 | 170 | 94.7% | |
| HF004 | 2020 | 177 | 188 | 94.1% |
